CannAssist International Corporation CNSC Archives

FridayFeb 19, 2021 10:43 am

CannAssist International Corp. (CNSC) Sees Product Popularity Grow as Professional Athletes Switch to CBD for Pain Relief

CBD-based products have become increasingly popular among professional athletes, primarily due to pain-relieving, anti-inflammatory qualities CannAssist International's Xceptor Labs is an active player within the CBD-based product sector through the development of its proprietary CiBiDinol technology CiBiDinol's technology, using a water-soluble carrier, developed an encapsulation process to deliver unchanged CBD molecule through cell's watery matrix Xceptor Labs has seen rapid uptake in products' popularity, with ten products now available for sale online When three-time National Football League tight end Rob Gronkowski first announced his retirement from professional football, he attributed part of the decision to the heavy toll that injuries and…

WednesdayFeb 17, 2021 1:47 pm

CannAssist International Corp. (CNSC) Focused on Leveraging Position in Growing Cannabis Industry through Strategic Marketing Plan

Vast opportunities exist in growing cannabis space CannAssist is committed to establishing aggressive marketing presence in promising market CannAssist brings impressive advancements, achievements to the table, including its propriety CiBiDinol technology Carefully developing and executing a strategic go-to-market plan has never been more important for companies operating in the cannabis industry, according to a recent “Rolling Stone” article (https://ibn.fm/u7v4y). The article urges cannabis companies to consider the industry from both a competitive perspective as well as an opportunity angle, which is exactly what CannAssist International (OTCQB: CNSC) has done as it looks toward 2021 and a projected $5.8 million share of…

WednesdayFeb 17, 2021 10:31 am

QualityStocksNewsBreaks – CannAssist International Corporation (CNSC) Featured in Latest Episode of The Bell2Bell Podcast

CannAssist (OTCQB: CNSC), the parent company of Xceptor Labs and developer of innovative CiBiDinol technology, was featured in an episode of The Bell2Bell Podcast, produced by InvestorBrandNetwork (“IBN”) as part of its sustained effort to provide specialized content distribution via widespread syndication channels. Bell2Bell’s latest podcast features Mark Palumbo, founder and CEO of CannAssist, as he discusses the company’s CiBiDinol technology. Palumbo noted that CannAssist’s platform, which was developed as a product of the company’s subsidiary, Xceptor Labs, is capable of improving the performance of CBD and a host of other oil-soluble active ingredients, including non-CBD cannabinoids, terpenes, essential oils…

ThursdayFeb 04, 2021 3:22 pm

QualityStocksNewsBreaks – CannAssist International Corporation (CNSC) Pioneers Promising CiBiDinol Technology

CannAssist (OTCQB: CNSC), a biotechnological pharmaceutical and wellness company, believes that its proprietary CiBiDinol technology will be a game-changer. According to a recent article, “the company believes that the amount of CBD needed to achieve the targeted therapeutic effects can be reduced significantly, resulting in reduced costs for both manufacturers and consumers.” CBD-based products “reduce inflammation while providing pain relief.” They are also the preferred option because they are “a gentler way to relieve pain and reduce inflammation,” unlike mainstream pharmaceuticals that have dangerous toxicity levels. CiBiDinol’s high efficacy per dose was the subject of “testing conducted via third-party services…

TuesdayFeb 02, 2021 2:54 pm

CannAssist International Corp. (CNSC) Proprietary Tech Is Core of CBD Products with Better Absorption

Absorption vital component of product effectiveness CNSC's proprietary CiBiDinol technology is cannabidiol made water compatible Xceptol products offer CBD in format more in line with body's natural bioactivity CannAssist International (OTCQB: CNSC) is a biotechnological pharmaceutical and wellness company marketing its exclusive Xceptol consumer brand. The company is the owner of Xceptor Labs, which uses proprietary technology to create Xceptol CBD products. The company complex has better absorption than currently marketed oil-based products — a key advantage when assessing products' effectiveness. Drug absorption, or the way a drug is absorbed into the bloodstream, is a vital component in the effectiveness…

FridayJan 29, 2021 2:23 pm

QualityStocksNewsBreaks – CannAssist International Corporation (CNSC) Leverages Proprietary Technology to Stand Distinct in Surging Market

CannAssist (OTCQB: CNSC), a biotechnological pharmaceutical and wellness company, rapidly garnered a reputation and loyal following due to its innovative technology and proprietary product line, marketed through its Xceptol consumer brand. The company was founded in May 2017 and moved to the forefront of the cannabidiol industry following the passing of the 2018 Farm Bill, whereby the United States effectively decriminalized the cultivation and use of hemp and its derivative products. The global cannabidiol (“CBD”) industry has since surged to new heights, set to rise from a market value of $4.6 billion in 2018 to an estimated $23.6 billion by…

ThursdayJan 28, 2021 3:20 pm

CannAssist International Corp. (CNSC) Addresses CBD Absorption Issues with Proprietary CiBiDinol Technology

CBD products in oil-based form have compromised bioavailability, according to experts CNSC's Xceptol CBD products created with proprietary CiBiDinol technology that addresses absorption issues for superior efficacy Third-party Xceptol testing shows 300% increased gut absorption, 400% increased skin penetration when compared to mainstream CBD oil products Growing in popularity in a myriad of markets, cannabidiol (“CBD”) is a phytocannabinoid that can mimic natural endocannabinoids in the human body for various therapeutic effects. Growing awareness around the use of oil-based CBD has led to skyrocketing popularity among the mainstream public despite bioavailability concerns among healthcare professionals and doctors (https://ibn.fm/d0Kab). CannAssist International (OTCQB:…

WednesdayJan 20, 2021 12:59 pm

CannAssist International Corp. (CNSC) Strengthens Position in Growing Sector with Exclusive Technology, Proprietary Line of CBD Products

Global cannabidiol market expected to increase almost sixfold by 2025 CNSC offers powerful line of CBD products under Xceptol brand CannAssist has forecast first-year sales of $5 million, with steady sales growth moving forward With industry experts predicting the stabilization of hemp prices and a more predictable market in 2021 (https://ibn.fm/q7JzX), CannAssist International (OTCQB: CNSC) appears to be ideally situated in a sector forecast for remarkable growth. Owner of Xceptor Labs, CannAssist is a biotechnological pharmaceutical and wellness company that markets a powerful line of cannabidiol (“CBD”) products under the Xceptol brand. “The hemp market’s volatility appears to be coming…

MondayJan 11, 2021 11:57 am

CannAssist International Corp.’s (CNSC) Proprietary Technology Offers Superior Absorption, Efficacy

Imperial College of London review suggests that cannabis-based medicinal products offer significant relief from intractable epilepsy CNSC produces proprietary CBD products under the Xceptol brand that are created with branded Technology CiBiDinol that increases absorbability, bioavailability, shelf life Third-party Xceptol testing shows 300% increased gut absorption, 400% increased skin penetration when compared to mainstream CBD oil products Researchers from the Imperial College of London recently conducted a review that examined the impact of cannabis-based medicinal products containing cannabidiol (“CBD”) on the frequency of epileptic seizures and determined that they offer patients significant relief from intractable epilepsy (https://ibn.fm/TDwpd). As scientific evidence…

ThursdayJan 07, 2021 1:06 pm

CannAssist International Corp. (CNSC) Flagship Brand Approved, Included by Powerful Online Platform

Acceptance of Xceptol products on RangeMe website new revenue source, increasing SKUs and access to retailers RangeMe enables retail buyers to discover innovative, emerging products; empowers suppliers to manage, grow their brands CannAssist developed Xceptol brand to offer effective health and wellness solutions without side effects CannAssist International (OTCQB: CNSC) has announced that its flagship brand — Xceptol — has been approved and included by the distribution website RangeMe (https://ibn.fm/c55wi). Xceptol's inclusion on the website means increasing SKUs, access to more than 10,000 retailers, and a significant new revenue source for CNSC. "This is exciting news for us on many fronts,"…

Site Search

Company Search

Tag: CannAssist International Corporation CNSC